https://www.selleckchem.com/pr....oducts/cdk2-inhibito
Private psychiatrists may continue to offer the majority of care, where practical, via telepsychiatry to reduce COVID-19 exposure risks, as well as allow for the realities of practice management for pandemic public health measures. However, consideration has to be given to the potential drawbacks for patients with sight, hearing and illness-related disabilities or risks, when in-person consultation is required. There are also risks some patients may not benefit from telepsychiatry due to the nature of their illness, and will p
Like
Comment
Share
